Sitagliptin in the Elderly.

Trial Profile

Sitagliptin in the Elderly.

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Oct 2017

At a glance

  • Drugs Sitagliptin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 14 Mar 2014 According to ClinicalTrials.gov record, status changed from active no longer recruiting to completed.
    • 10 Aug 2011 Planned end date changed from Dec 2011 to Dec 2013 as reported by ClinicalTrials.gov.
    • 23 Sep 2010 Planned end date changed from 1 Dec 2008 to 1 Dec 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top